Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mix paired-like homeobox protein 1 (MIXL1) is a paired-type homeobox transcription factor found in humans and is part of the Mix/Bix homeobox gene family[1][2]. It is expressed transiently in the primitive streak during early embryogenesis, marking precursors that will become mesoderm and endoderm[1][2][4]. MIXL1 regulates essential developmental processes by activating genes required for mesoderm formation, hematopoiesis, and definitive endoderm development[1][3][4][5]. It functions as a dimeric, sequence-specific transcriptional activator, often responding to external signals such as BMP4, Nodal, and other TGF-β family ligands to guide cell fate during gastrulation[2][3][4]. Loss of MIXL1 disrupts embryonic axis formation, cardiac and gut development, and blood cell differentiation[1][3][4]. MIXL1 has been detected in leukemic cell lines and implicated in some cancers when aberrantly expressed[1]. There are currently no known therapeutic drugs that specifically target MIXL1, and its main utility as a biomarker is limited to research applications in developmental biology and stem cell lineage tracing[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mix paired-like homeobox protein 1 (MIXL1).